Business Wire

Minute Molecular’s DASH Point-of-Care COVID-19 Rapid PCR Test Gains FDA Emergency Use Authorization

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
Newsweek

Hands-On With Detect’s New Home COVID-19 Molecular Test

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. As the COVID-19 pandemic approaches the two-year mark, more at-home ...
Nasdaq

Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
MarketWatch

Breaking the PCR-Only Barrier: Dual 510(k) Clearance and CLIA-Waiver Establish FINDER as the First Molecular Point-of-Care Platform with Multifunctional Capabilities

The MarketWatch News Department was not involved in the creation of this content. DURHAM, N.C., March 31, 2026 /PRNewswire/ -- Baebies announced FDA 510(k) clearance and CLIA-waiver approval for the ...
News Medical

Ultrafast PCR technology shortens the test time by 10-fold

PCR technology is a molecular diagnostics technology that detects target nucleic acids by amplifying the DNA amount. It has brought marked progress in the life sciences field since its development in ...

ABL Diagnostics Secures New Global Tenders and Continues to Expand Distribution Network

ABL Diagnostics accelerates international growth with key public contracts and platform-agnostic microbiology solutions ...

Countable Labs Raises $26 Million to Accelerate Clinical Product Development and Global Commercialization of Countable PCR

Countable Labs raises $26 million. Company shares plans for new products to support clinical testing applications and announces hire of sales leader.